3 Comments

Dr. Bhakdi is a highly accomplished and respected Thai-German Microbiologist, and has (co-)authored 314 PubMed publications, many of which are highly cited. Despite being heavily censored and "fact-checked," he has continued to raise the alarm about the plandemic and Covid-19 "vaccines."

https://open.substack.com/pub/lionessofjudah/p/dr-sucharit-bhakdi-urgent-message?r=n7rts&utm_campaign=post&utm_medium=email

Expand full comment

I will not be listening to any "news" or "olds" or much of any thing that is mass produced. Looking more like a total detox is needed.

Expand full comment

"vaccines" are neither safe or effective. " Effectiveness was not demonstrated when the XBB lineages were dominant." Right Action involving prevention and early treatment are key

"Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine" Cleveland Clinic study: "Risk of COVID-19 also increased with time since most recent prior COVID-19 episode and with the number of vaccine doses previously received"  "and effectiveness was not demonstrated when the XBB lineages were dominant."

In minnesota  XBB, a sublineage of BA.2, is the dominant variant, making up 96% of the viral RNA entering the plant last week.

https://www.cidrap.umn.edu/covid-19/cidrap-unveils-roadmap-advancing-better-coronavirus-vaccines

"Improved understanding of the role of immune imprinting from prior infection and vaccination will be critical to advance new vaccine R&D," the group emphasized in the CVR."  my note:    "CRITICAL"

Clear acknowledgement of the facts known showing that when you take a vaccine, and take it again and again and again, that stimulates your body make antibodies that do not stop infection your body can and does get stuck producing failed antibodies

https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v5  "Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine"ABSTRACTBackground The purpose of this study was to evaluate whether a bivalent COVID-19 vaccine protects against COVID-19.Methods Employees of Cleveland Clinic in employment when the bivalent COVID-19 vaccine first became available, were included.Results Among 51017 employees, COVID-19 occurred in 4424 (8.7%) during the study. ....   Estimated vaccine effectiveness (VE) was ... 4% (95% C.I., -12%-18%), during the  XBB dominant phases ... . Risk of COVID-19 also increased with time since most recent prior COVID-19 episode and with the number of vaccine doses previously received. MY NOTE: Risk of COVID-19 also increased

Conclusions The bivalent COVID-19 vaccine given to working-aged adults afforded modest protection overall against COVID-19 while the BA.4/5 lineages were the dominant circulating strains, afforded less protection when the BQ lineages were dominant, and effectiveness was not demonstrated when the XBB lineages were dominant.Summary Among 51017 working-aged Cleveland Clinic employees, the bivalent COVID-19 vaccine was 29% effective in preventing infection while the BA.4/5 lineages were dominant, and 20% effective while the BQ lineages were. Effectiveness was not demonstrated when the XBB lineages were dominant.

Note: the amount of covid in the population in the Minneapolis area (and in the vaccinated countries), appeares have been this past year at a sustained higher average level than the average of the high and low points in the first 2 years of the pandemic.  Covid is very much still here but very much lower right now.

https://metrocouncil.org/Wastewater-Water/Services/Wastewater-Treatment/COVID19-Research.aspx

Expand full comment